Fazliana Mansor1*, Nur Azlin Zainal Abidin1, Liyana Ahmad Zamri1, Tan You Zhuan Tan2, Farah Huda Mohkiar2, Zubaidah Nor Hanipah3, Poh Yue Tsen4,5,6, Syu Yu Lim4,5,6, Tikfu Gee4,5,6
1. Endocrine & Metabolic Unit, Nutrition, Metabolism and Cardiovascular Research Centre, Institute for Medical Research, National Institutes of Health, Setia Alam 40170, Shah Alam, Selangor, Malaysia
2. Cardiovascular Unit, Nutrition, Metabolism and Cardiovascular Research Centre, Institute for Medical Research, National Institutes of Health, Setia Alam 40170, Shah Alam, Selangor, Malaysia
3. Faculty of Medicine and Health Sciences, University Putra Malaysia, Serdang 43400, Selangor, Malaysia
4. iHeal Medical Centre, Menara IGB, Mid Valley City, 59200 Kuala Lumpur, Malaysia
5. Sunway Medical Centre, Bandar Sunway, 47500 Selangor, Malaysia
6. Sunway Velocity Medical Centre, Lingkaran SV2, Sunway Velocity, 55100 Kuala Lumpur, Malaysia
*Corresponding author: Fazliana Mansor.
ABSTRACT
INTRODUCTION: MicroRNAs (miRNAs) are important gene expression regulators and key players in controlling several biological and pathological processes, including type 2 diabetes (T2D). The plasma or serum miRNA profile is deregulated in prediabetic conditions before the onset of T2D. An alteration in circulating miRNAs may have significant diagnostic and therapeutic relevance in patients with diabetes and obesity.
OBJECTIVE(S): This study aimed to investigate the miRNA levels in obese patients with prediabetes who underwent sleeve gastrectomy, a type of bariatric surgery.
MATERIALS & METHODS: Nine (9) prediabetic patients with obesity who underwent sleeve gastrectomy at three private hospitals in Klang Valley, Malaysia, were recruited. Clinical data and serum samples were collected preoperatively and at a 6-month follow-up. Body mass index (BMI) and HbA1c were measured. miRNA was isolated from serum. Quantifying miRNA in serum was performed using the Qubit® MicroRNA Assay Kit. miRNA was then converted to cDNA and subjected to quantitative real-time polymerase chain reaction (q-PCR) using the miRCURY LNA Focus Panel. Data was analysed using the GeneGlobe Data Analysis Center. Different levels of expressed serum miRNAs were identified, comparing pre- and post-6-month sleeve gastrectomy.
RESULTS: After six months, all patients' BMI and HbA1c levels were reduced by 8.7 kg/m2 (95% CI: 6.35 - 11.1 kg/m2; p < 0.0001), and 1.65% (95% CI: 0.713 - 2.60%; p = 0.0029) respectively. Following a qPCR-based analysis of circulating serum microRNAs, results showed that miR-19a-3p, involved in vascular homeostasis and atheroprotection, was significantly upregulated (2.97-fold, p<0.05). There was significant downregulation of miR-375-3p, which is involved in cardiac dysfunction and cardiogenesis (4.02-fold, p<0.05). miR-15b-5p, elevated by high glucose in all these prediabetic patients, was significantly reduced by 2.60-fold post-surgery.
CONCLUSION: Our study revealed significant changes in miRNA levels among prediabetic patients post-sleeve gastrectomy, suggesting their potential as prognostic markers in obesity-related diabetes.
KEYWORDS: MicroRNA, Obesity, Prediabetes, Bariatric Surgery, Sleeve Gastrectomy


